Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Melatonin (meta)
Aspirin (meta) Metformin (meta)
Bamlaniv../e.. (meta) Molnupiravir (meta)
Bebtelovimab (meta) N-acetylcys.. (meta)
Bromhexine (meta) Nigella Sativa (meta)
Budesonide (meta) Nitazoxanide (meta)
Cannabidiol (meta) Nitric Oxide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)
Lactoferrin (meta)

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Mortality 65% Improvement Relative Risk Severe case 62% c19vitamind.com D’Ecclesiis et al. Vitamin D for COVID-19 META Favors vitamin D Favors control
D’Ecclesiis, vitamin D meta analysis: 65% lower mortality [p=0.004] and 62% lower severe cases [p=0.003] https://c19p.org/decclesiis
copied to clipboard
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis
D’Ecclesiis et al., PLOS ONE, doi:10.1371/journal.pone.0268396 (meta analysis)
6 Jul 2022    Source   PDF   Share   Tweet
Systematic review showing significantly lower risk of mortality and severe cases with vitamin D supplementation, and for high vs. low vitamin D levels.
Currently there are 85 vitamin D for COVID-19 studies, showing 37% [26‑47%] lower mortality, 32% [4‑53%] lower ventilation, 50% [30‑65%] lower ICU admission, 22% [12‑31%] lower hospitalization, and 12% [2‑21%] lower cases.
risk of death, 65.0% lower, RR 0.35, p = 0.004, supplementation.
risk of severe case, 62.0% lower, RR 0.38, p = 0.003, supplementation.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
D’Ecclesiis et al., 7/6/2022, peer-reviewed, 19 authors.
Contact: patrizia.gnagnarella@ieo.it, sara.gandini@ieo.it.
All Studies   Meta Analysis
This PaperVitamin DAll
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit